Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy.
作者信息
Belldegrun A, Koo A S, Bochner B, Figlin R, deKernion J B
机构信息
Department of Surgery, University of California, Los Angeles.
出版信息
Eur Urol. 1990;18 Suppl 2:42-5. doi: 10.1159/000463962.
PMID:2226609
Abstract
摘要
相似文献
1
Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy.晚期肾细胞癌的免疫治疗：根治性肾切除术的作用。
Eur Urol. 1990;18 Suppl 2:42-5. doi: 10.1159/000463962.
2
Management of advanced renal cancer.晚期肾癌的管理
Kidney Int. 2005 May;67(5):2069-82. doi: 10.1111/j.1523-1755.2005.00309.x.
3
The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.根治性肾切除术后辅助免疫治疗的作用及pT3N0M0肾细胞癌的预后因素
Anticancer Res. 1999 Nov-Dec;19(6C):5593-7.
4
[Adjuvant therapy with vinblastine and interferon in metastatic renal carcinoma].[长春碱与干扰素辅助治疗转移性肾癌]
Minerva Urol Nefrol. 1989 Jul-Sep;41(3):187-9.
5
6
Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?长春花碱在治疗肾细胞癌时会增强α干扰素的效力吗？
Mol Biother. 1991 Mar;3(1):34-7.
7
8
Metastasectomy plus immunotherapy compared with immunotherapy alone in metastatic renal cell carcinoma.转移性肾细胞癌中，转移灶切除术联合免疫疗法与单纯免疫疗法的比较。
Clin Oncol (R Coll Radiol). 2007 Mar;19(2):164-5. doi: 10.1016/j.clon.2006.11.001.
9
Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?对于pT2-3N0M0肾细胞癌，根治性肾切除术后辅助免疫化疗是否有作用？
J Chemother. 1995 Jun;7(3):240-5. doi: 10.1179/joc.1995.7.3.240.
10
[Metastasizing kidney cancer. Experience with interferon alfa-2a and vinblastine].[转移性肾癌。使用干扰素α-2a和长春碱的经验]
Actas Urol Esp. 1990 Sep-Oct;14(5):335-8.
Zotero 插件